Bank of Montreal
INM icon

Bank of Montreal’s InMed Pharmaceuticals INM Stock Holding History

Bank of Montreal’s Portfolio INM Stock Details INM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Hold
0
– -$1K – 4261
2021
Q1 		– Sell
-1
Closed -$2.15K – 4984
2020
Q4 		$1K Buy
+1
New +$1.62K ﹤0.01% 4873

Other funds holding INM

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
PCM
Penserra Capital Management Orinda, California $8.52B AUM 37.76% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
AWM
AllSquare Wealth Management Albany, New York $189M AUM 14.89% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
RFA
Reilly Financial Advisors La Mesa, California $1.35B AUM 22.65% 1-Year Est. Return

Bank of Montreal's INM Position: Q2 2021 in Review

Bank of Montreal held its InMed Pharmaceuticals (INM) position steady in Q2 2021 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #4261.

Bank of Montreal first reported a position in INM in Q4 2020 and has held it in 1 quarter since. The position peaked at $1K in Q4 2020. 13 funds tracked by Wall St. Rank hold INM as of Q2 2021.

  • Bank of Montreal held 0 shares of InMed Pharmaceuticals worth $0 as of Q2 2021.
  • Bank of Montreal left its InMed Pharmaceuticals share count unchanged in Q2 2021.
  • InMed Pharmaceuticals made up ﹤0.01% of Bank of Montreal's portfolio in Q2 2021, its #4261 holding.
  • Bank of Montreal first reported a position in InMed Pharmaceuticals in Q4 2020 and has held it in 1 quarter since.
  • Bank of Montreal's InMed Pharmaceuticals position peaked at $1K in Q4 2020.
  • 13 funds tracked by Wall St. Rank held InMed Pharmaceuticals as of Q2 2021.

Based on Bank of Montreal's 13F filing for Q2 2021, filed 12 Aug 2021.